Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Thermo Fisher Scientific
MedTech
Thermo Fisher Scientific sells off microbiology business for $1B
Thermo Fisher Scientific is shedding its microbiology business to a private equity firm nearly a year after rumors of a potential sale first surfaced.
Ben Adams
Apr 27, 2026 10:10am
Thermo Fisher unveils test for dosing of antirejection drug
Feb 27, 2026 5:20am
Fierce Pharma
Thermo Fisher winds down Boston area plant
Feb 2, 2026 12:22pm
Thermo Fisher teams up with Nvidia, TetraScience
Jan 12, 2026 3:22pm
Thermo Fisher to buy Clario in $9B deal
Oct 31, 2025 12:41pm
Thermo Fisher launches biopsy test to assess lung rejection risk
Oct 9, 2025 10:50am
